IgE Allergy Blood Tests Market Analysis

  • Report ID: 5551
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

IgE Allergy Blood Tests Market Segmentation:

End-User Segment Analysis

The diagnostics laboratories segment in the IgE allergy blood tests market is estimated to gather the highest share of over 40% during the forecast period. Diagnostic lab services are essential to the healthcare industry since they are vital to the diagnosis and management of diseases. Furthermore, a clear role for the diagnostics laboratory exists in the diagnosis and treatment of allergy sufferers. Furthermore, diagnostics laboratories have a huge availability of funds and the latest technology as compared to hospitals. In the past, when diagnostic testing services were less developed, medical professionals relied on a patient's symptoms to determine what was allegedly wrong and recommend medication. Frequently, the patient's symptoms were ambiguous, and the wrong problem was being addressed. However, this is no longer an issue as a result of developments in technology and medicine. Diagnostic centers today offer several examinations for allergies. As a result, the preference for diagnostics laboratories is growing.

Application Segment Analysis

The food allergies segment is expected to hold 30% share of the global IgE allergy blood tests market during the forecast period. In addition to being obtained through food, vitamin D is produced by the human body when exposed to sunshine. Due in large part to the immune system's regulation by vitamin D, the prevalence of food allergies has risen as vitamin D levels have decreased between nations. According to study data, 50% of the global population suffers from vitamin D insufficiency, while approximately 1 billion people worldwide suffer from vitamin D deficiency.

Our in-depth analysis of the global IgE allergy blood tests market includes the following segments:

     Product Type

  • Assays & Kits
  • ELISA Testing Kits
  • Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
  • Chemiluminescent Immunoassays (CLIA)
  • Reagents, Consumables
  • Analyzers

     Application

  • Aero Allergies, Indoor Allergies
  • Outdoor Allergies
  • Food Allergies
  • Venoms
  • Medicine Allergies
  • Latex/Metal Allergies

     End-User

  • Diagnostic Laboratories
  • Specialty Clinics
  • Hospitals
  • Research & Academic Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of IgE allergy blood tests is evaluated at USD 36.19 billion.

The global IgE allergy blood tests market size was worth over USD 34.19 billion in 2025 and is poised to grow at a CAGR of around 6.5%, reaching USD 64.18 billion revenue by 2035.

North America igE allergy blood tests market will hold more than 30% share by 2035, driven by growing adoption of health insurance and advanced testing instruments.

Key players in the market include Thermo Fisher Scientific Inc., Siemens Healthineers AG, Hycor Biomedical, LLC, Euroimmun AG (PerkinElmer), Quest Diagnostics Incorporated, LabCorp (Laboratory Corporation of America Holdings), Bio-Rad Laboratories, Inc., GenWay Biotech, Inc., Alere Inc. (Abbott), Stallergenes Greer.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos